Polyrizon Ltd.(PLRZ)

Biotechnology · Ra'anana, TA

$9.67+0.32 (+3.42%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

PE Ratio: N/A

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T22:32:56.400Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:32:56.400Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 9.6697
Unrounded diluted TTM EPS · period ending 2026-06-30: N/A

FMP input reference: 94b5ad3735cc71b9af2236876c301d5f64b1c42b83610b62f031870796dba4d5

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

PLRZ PE Ratio Metrics

PE RATIO

N/A

PLRZ Competitors' PE Ratio

PLRZ

Polyrizon Ltd.

Current

Market Cap

$10.83M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs PLRZ

Market Cap

$10.86M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNSY

Cerenome, Inc.

vs PLRZ

Market Cap

$10.94M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PLUR

Pluri Inc.

vs PLRZ

Market Cap

$10.68M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GDTC

CytoMed Therapeutics Limited

vs PLRZ

Market Cap

$11.00M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LSTA

Lisata Therapeutics, Inc.

vs PLRZ

Market Cap

$11.02M

PE Ratio

N/A

TTM Avg

2.09

3Y Avg

2.09

5Y Avg

2.09

KPRX

Kiora Pharmaceuticals, Inc.

vs PLRZ

Market Cap

$11.08M

PE Ratio

N/A

TTM Avg

2.43

3Y Avg

2.43

5Y Avg

2.43

VTGN

VistaGen Therapeutics, Inc.

vs PLRZ

Market Cap

$11.12M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs PLRZ

Market Cap

$10.45M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs PLRZ

Market Cap

$11.36M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Polyrizon Ltd. (PLRZ)	$10.83M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$10.86M	N/A	N/A	N/A	N/A
Cerenome, Inc. (CNSY)vs ›	$10.94M	N/A	N/A	N/A	N/A
Pluri Inc. (PLUR)vs ›	$10.68M	N/A	N/A	N/A	N/A
CytoMed Therapeutics Limited (GDTC)vs ›	$11.00M	N/A	N/A	N/A	N/A
Lisata Therapeutics, Inc. (LSTA)vs ›	$11.02M	N/A	2.09	2.09	2.09
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.08M	N/A	2.43	2.43	2.43
VistaGen Therapeutics, Inc. (VTGN)vs ›	$11.12M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$10.45M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$11.36M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

PLRZ PE Ratio Metrics

PLRZ Competitors' PE Ratio

P/E Comparison

PE Ratio Formula & Definition

Related Metrics